Compare Bumble Inc (BMBL) vs Novartis AG (NVS) Price & Performance

Bumble IncTrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

Bumble Inc vs Novartis AG — how do they compare? Bumble Inc trades at $2.82 (market cap $366.87M), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 805.1× Bumble Inc's market cap, and Novartis AG pays a 3.07% dividend while Bumble Inc pays none. Which is the better fit depends on your goals.

	BMBL	NVS
Market Cap	$366.87M	$295.37B
Sector	Technology	Health
52-Week High	$7.17	$168.62
52-Week Low	$2.70	$119.31
Enterprise Value	$672.73M	$336.69B
Dividend Yield	—	3.07%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMBL

Bumble drops women-first messaging rule, allowing anyone to message first with a 72-hour reply window.TechCrunch · 1 day agoBearish View details →

NVS

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

About Bumble Inc

Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.